Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Encephalitis Vaccines
Scientists at China Medical University detail research in encephalitis vaccines
March 12th, 2008
Fresh data on encephalitis are presented in the report 'Protective immunity of E. coli-synthesized NS1 protein of Japanese encephalitis virus.' According to a study from Taichung, Taiwan, "Immunogenicity and protective efficacy of recombinant Japanese encephalitis virus (JEV) NS1 proteins generated using DNA vaccines and recombinant viruses have been demonstrated to induce protection in mice against a challenge of JEV at a lethal dose. The West Nile virus NS1 region expressed in E. coli is recognized by these protective monoclonal antibodies and, in this study, we compare immunogenicity and protective immunity of the E. coli-synthesized NS1 protein with another protective...
Source: Vaccine Weekly (2008-03-12)
|
